Results 231 to 240 of about 66,190,054 (394)

DP049 | ABSTRACT WITHDRAWN

open access: yesHaematologica
Not presented.
Data not available.
doaj  

Data, data, data…

open access: yesInternational Journal of Clinical Practice, 2007
openaire   +2 more sources

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

P162 | ABSTRACT WITHDRAWN

open access: yesHaematologica
Not presented.
Data not available.
doaj  

Extreme Rainfall Contribution and Isotopic Excursion of Tropical Storm Alberto in Northeastern Mexico. [PDF]

open access: yesRapid Commun Mass Spectrom
Ibarra-Alejos OJ   +7 more
europepmc   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

open access: yesMolecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski   +19 more
wiley   +1 more source

P168 | ABSTRACT WITHDRAWN

open access: yesHaematologica
Not presented.
Data not available.
doaj  

Home - About - Disclaimer - Privacy